Looks like there`s been an error while trying to load this page.
Our team has been notified but please contact us using the email support widget if the problem persists.
Metrics | Range | Conclusion |
---|---|---|
Selected LTM Pb Multiple | 3.7x - 4.1x | 3.9x |
Historical Pb Multiple | 1.9x - 6.1x | 4.2x |
Fair Value | ₹42.59 - ₹47.08 | ₹44.84 |
Upside | 3.5% - 14.4% | 8.9% |
Benchmarks | - | Full Ticker |
Paradeep Phosphates Limited | 54,353,000.0% | BSE:543530 |
Link Pharma Chem Limited | 52,474,800.0% | BSE:524748 |
Yasho Industries Limited | 54,116,700.0% | BSE:541167 |
Gujarat Fluorochemicals Limited | 54,281,200.0% | BSE:542812 |
3B Blackbio Dx Limited | 53,206,700.0% | BSE:532067 |
Caprolactam Chemicals Limited | 50,748,600.0% | BSE:507486 |
Select Price / Book Ratio | ||||||||
Benchmark Companies | ||||||||
543530 | 524748 | 541167 | 542812 | 532067 | 507486 | |||
BSE:543530 | BSE:524748 | BSE:541167 | BSE:542812 | BSE:532067 | BSE:507486 | |||
Historical Net Income Growth | ||||||||
5Y CAGR | -8.9% | NM- | 37.3% | -19.0% | 43.7% | -17.0% | ||
3Y CAGR | -23.5% | NM- | 39.2% | NM- | -34.4% | -32.8% | ||
Latest Twelve Months | 367.5% | 77.0% | -65.8% | -31.5% | 50.0% | -156.8% | ||
Historical Net Income Profit Margin | ||||||||
5 Year Average Margin | 3.0% | 1.3% | 7.4% | 10.8% | 41.7% | 0.5% | ||
Prior Fiscal Year | 2.3% | 1.7% | 10.1% | 23.4% | 41.8% | 25.9% | ||
Latest Fiscal Year | 0.9% | -4.6% | 9.8% | 10.2% | 43.2% | 2.8% | ||
Latest Twelve Months | 3.3% | -1.5% | 2.9% | 9.8% | 48.9% | -2.1% | ||
Return on Equity | ||||||||
5 Year Average Margin | 9.5% | 4.7% | 30.9% | 11.1% | 46.2% | 10.5% | ||
Prior Fiscal Year | 10.6% | 4.4% | 33.0% | 27.2% | 15.0% | 62.6% | ||
Latest Twelve Months | 11.5% | -3.1% | 6.8% | 7.7% | 20.9% | -2.6% | ||
Next Fiscal Year | 11.7% | #NUM! | 17.3% | 8.8% | 16.6% | 0.0% | ||
Two Fiscal Years Forward | 14.0% | -10.5% | 14.8% | 14.1% | 15.7% | 0.0% | ||
Current Trading Multiples | ||||||||
Price / LTM Sales | 0.8x | 0.6x | 3.2x | 8.9x | 15.4x | 2.9x | ||
Price / LTM EPS | 23.1x | -38.6x | 109.8x | 90.7x | 31.4x | -134.6x | ||
Price / Book | 2.5x | 1.2x | 7.0x | 6.7x | 6.1x | 3.6x | ||
Price / Fwd Book | 2.4x | 1.1x | 5.9x | 6.5x | 5.7x | 3.4x | ||
Low | Mid | High | ||||||
Benchmark P/B Ratio | 1.2x | 6.1x | 7.0x | |||||
Historical P/B Ratio | 1.9x | 4.2x | 6.1x | |||||
Selected P/B Multiple | 3.7x | 3.9x | 4.1x | |||||
(x) Book Value | 53 | 53 | 53 |
Equity Value | |||||||
Benchmark Companies | |||||||
(in millions) | 543530 | 524748 | 541167 | 542812 | 532067 | 507486 | |
Value of Common Equity | 97,132 | 155 | 20,693 | 422,373 | 14,800 | 189 | |
(/) Shares Outstanding | 815.2 | 4.4 | 12.1 | 109.9 | 8.6 | 4.6 | |
Implied Stock Price | 119.15 | 34.96 | 1,716.25 | 3,845.00 | 1,727.25 | 41.17 | |
FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
Implied Stock Price (Trading Cur) | 119.15 | 34.96 | 1,716.25 | 3,845.00 | 1,727.25 | 41.17 | |
Trading Currency | INR | INR | INR | INR | INR | INR | |
FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |